Literature DB >> 16099805

RANK ligand and osteoprotegerin: emerging roles in mucosal inflammation.

A J Ashcroft, S R Carding.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16099805      PMCID： PMC1774648          DOI： 10.1136/gut.2005.070623

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

Review 1.  RANK-L and RANK: T cells, bone loss, and mammalian evolution.

Authors:  Lars E Theill; William J Boyle; Josef M Penninger
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis.

Authors:  H L Neville-Webbe; N A Cross; C L Eaton; R Nyambo; C A Evans; R E Coleman; I Holen
Journal:  Breast Cancer Res Treat       Date:  2004-08       Impact factor: 4.872

3.  Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.

Authors:  Claire M Shipman; Peter I Croucher
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

4.  Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin.

Authors:  A J Ashcroft; S M Cruickshank; P I Croucher; M J Perry; S Rollinson; J M Lippitt; J A Child; C Dunstan; P J Felsburg; G J Morgan; S R Carding
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.